Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

被引：0

作者：

Silverberg, Jonathan, I ^{[1
]}

Bieber, Thomas ^{[2
,3
]}

Paller, Amy ^{[4
]}

Beck, Lisa A. ^{[5
]}

Kamata, Masahiro ^{[6
]}

Puig, Luis ^{[7
]}

Wiseman, Marni ^{[8
,9
]}

Ezzedine, Khaled ^{[10
]}

Foley, Peter ^{[11
]}

Johansson, Erin ^{[12
]}

Dossenbach, Martin ^{[12
]}

Akmaz, Bulent ^{[13
]}

Casillas, Marta ^{[12
]}

Karlsson, Andrei ^{[14
]}

Chovatiya, Raj ^{[15
]}

机构：

[1] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA

[2] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany

[3] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland

[4] Northwestern Univ, Dept Dermatol, Chicago, IL USA

[5] Univ Rochester, Med Ctr, Rochester, NY USA

[6] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan

[7] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain

[8] Univ Manitoba, Sect Dermatol, Winnipeg, MB, Canada

[9] SKiNWISE Dermatol, Winnipeg, MB, Canada

[10] Univ Paris Est, EpiDermE, Paris, France

[11] Skin Hlth Inst, Melbourne, Vic, Australia

[12] Eli Lilly & Co, Indianapolis, IN USA

[13] Almirall SA, Barcelona, Spain

[14] Costello Med, London, England

[15] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷

关键词：

atopic dermatitis; lebrikizumab; network meta-analysis; targeted systemic therapy;

D O I：

10.1093/bjd/ljae266.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

630

引用

页码：15 / 16

页数：2

共 50 条

[41] Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis
Shahwan, Kathryn T.
Kimball, Alexa B.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1198 - +
[42] Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials
Zirwas, Matthew J.
Boguniewicz, Mark
Rosmarin, David
Fuxench, Zelma Chiesa
Warren, Richard B.
Torres, Tiago
de Bruin-Weller, Marjolein
Dawson, Zach
Atwater, Amber Reck
Elmaraghy, Hany
Pierce, Evangeline
Bardolet, Laia
Zhong, Jinglin
Armstrong, April W.
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 54 - 56
[43] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Gold, Linda Stein
Thaci, Diamant
Thyssen, Jacob P.
Gooderham, Melinda
Laquer, Vivian
Moore, Angela
Natalie, Chitra R.
Zhao, Fangyi
Meskimen, Eric
Elmaraghy, Hany
Montmayeur, Sonia
Gallo, Gaia
Jimenez, Gemma
de Bruin-Weller, Marjolein
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 595 - 607
[44] Lebrikizumab is an effective treatment for moderate-to-severe atopic dermatitis in patients ≥60 years of age
Armstrong, April
Zirwas, Matthew
Napolitano, Maddalena
Torres, Tiago
Staumont-Salle, Delphine
Atwater, Amber Reck
Dossenbach, Martin
Agell, Helena
Chen, Sherry
Qiao, Meihua
Pierce, Evangeline
Piruzeli, Maria Lucia Buziqui
Mostaghimi, Arash
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[45] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Linda Stein Gold
Diamant Thaçi
Jacob P. Thyssen
Melinda Gooderham
Vivian Laquer
Angela Moore
Chitra R. Natalie
Fangyi Zhao
Eric Meskimen
Hany Elmaraghy
Sonia Montmayeur
Gaia Gallo
Gemma Jimenez
Marjolein de Bruin-Weller
American Journal of Clinical Dermatology, 2023, 24 : 595 - 607
[46] EFFICACY OF BRODALUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS: A NETWORK META-ANALYSIS
Xue, W.
Barbeau, M.
Khoudigian-Sinani, S.
Gray, E.
Saharia, P.
Frieder, D.
VALUE IN HEALTH, 2018, 21 : S239 - S239
[47] Comparative efficacy and safety of systemic therapies used in adult and adolescent moderate-to-severe atopic dermatitis (AD): A systematic literature review (SLR) and network meta-analysis (NMA)
Silverberg, Jonathan I.
Thyssen, Jacob P.
Fahrbach, Kyle
Mickle, Kristin
Cappelleri, Joseph C.
Romero, William
Cameron, Michael C.
Myers, Daniela E.
Clibborn, Claire
DiBonaventura, Marco
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB34 - AB34
[48] Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Gao, Qin
Zhao, Yanxia
Zhang, Junling
HELIYON, 2023, 9 (06)
[49] Efficacy and safety of baricitinib for the treatment of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis of randomized clinical trials
Wang, Bin
Pan, Shuaixi
Yao, Yue
Zeng, Linxi
Zhang, Guoqiang
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (11) : 1139 - 1149
[50] Advances in Systemic Treatment for Adults With Moderate-to-Severe Atopic Dermatitis
Cho, Yung-Tsu
Chu, Chia-Yu
DERMATOLOGICA SINICA, 2019, 37 (01) : 3 - 11

← 1 2 3 4 5 →